Literature DB >> 64857

Histocompatibility antigens as markers of abnormal iron metabolism in patients with idiopathic haemochromatosis and their relatives.

A Bomford, A L Eddleston, L A Kennedy, J R Batchelor, R Williams.   

Abstract

HLA-A3 was significantly more common in 35 unrelated patients with idiopathic haemochromatosis (69%) than in 95 controls (31%). Further studies in two families suggest that 2 genes are involved in the pathogenesis of the disease, each associated with a separate metabolic defect. Whereas minor abnormalities, namely raised serum-iron and some increase in storage iron, were found in relatives with an HLA A11, B27, CW2 haplotype, those with the A3, B14, CW5 haplotype had no detectable abnormalities. When both these haplotypes were found together, as in the propositus and one sibling in the first family investigated, all the signs of the fully developed disease were apparent. It is suggested that one of the genes is in linkage disequilibrium with HLA-A3 and could be responsible for a kinetic abnormality, possibly increased plasma to storage iron exchange. The other gene, also carried on the sixth chromosome and, in the first family, marked by the HLA A11, B27, CW2 haplotype might result in an increased absorption of dietary iron. The concomitant inheritance of these two genes and the metabolic defects they determine are required for the full development of the disease

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 64857     DOI: 10.1016/s0140-6736(77)91133-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

Review 1.  Genetic haemochromatosis.

Authors:  A B Bomford; I W Dymock; E B Hamilton
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association.

Authors:  M Simon; L Le Mignon; R Fauchet; J Yaouanq; V David; G Edan; M Bourel
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

3.  The distribution of HLA-Antigens in German patients with idiopathic hemochromatosis.

Authors:  H Dyrszka; G Eberhardt; G Eckert
Journal:  Klin Wochenschr       Date:  1979-05-16

4.  Ferritin in erythrocytes and plasma of patients with iron overload.

Authors:  H H Bodemann; R F Tanzi-Fetta; H Schröter-Urban; B A Volk; J Keul; G W Löhr
Journal:  Blut       Date:  1985-07

5.  Histocompatibility antigens as markers of abnormal iron metabolism in idiopathic hemochromatosis.

Authors:  D A Lloyd; P Adams; N R Sinclair; C R Stiller; L S Valberg
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

6.  Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload.

Authors:  M B Van Der Weyden; H Fong; H H Salem; R G Batey; F J Dudley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-05

7.  HLA as a marker of the hemochromatosis gene in Sweden.

Authors:  B Ritter; J Säfwenberg; K S Olsson
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  Relationship between serum ferritin and total body iron stores in idiopathic haemochromatosis.

Authors:  L W Powell; J W Halliday; J L Cowlishaw
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

9.  The detection of early hemochromatosis.

Authors:  L W Powell; J W Halliday
Journal:  Am J Dig Dis       Date:  1978-04

10.  Idiopathic familial hemochromatosis: limited disease extent with prolonged survival and arthritis.

Authors:  J L De Greve; L A Verbruggen; D Schallier; B Van Camp
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.